Hypericum monogynum
Hypericum monogynum · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Hypericum monogynum is a versatile plant species where the flowers, leaves, and roots serve as significant sources of bioactive compounds. Scientific studies highlight its potential medicinal activities, specifically its antidiabetic and neuroprotective properties. These therapeutic effects are largely attributed to key chemical constituents such as flavone, hyperielliptone HA, hyperoside, and PPAPS. Through various preparations like extracts and flower infusions, the plant shows promise in managing physiological conditions such as insulin resistance. Consequently, this species represents an important subject of interest in natural pharmacology and metabolic health research.
- Synonyms
- Ascyrum Monogynum · Hypericum Chinense Subsp. Obtusifolium · 10 more
- Common names
- Not available
- Family
- Hypericaceae
- Distribution
- Not available
- Plant Parts
- Flower · Leaf
Classification
Common Names
Hypericum monogynum is a diverse botanical species known by a variety of names across different cultures and languages. In English-speaking contexts, it is frequently referred to as Chinese St. John's wort or by its more formal botanical common name, Millepertuis monogyne. The plant also holds significant recognition in East Asia, where it is identified by several distinct regional titles. For instance, it is known in Japan as ビヨウヤナギ, while in Chinese-speaking regions, it is called 金絲桃 or 金線海棠. These various designations reflect the plant's widespread presence and cultural importance throughout its natural habitat.
Sources: Catalogue of Life (COL)
Synonyms
Hypericum monogynum is a botanical entity that is frequently identified through various taxonomic synonyms. Within scientific literature, it is often referred to by the name Ascyrum monogynum. The plant is also known by the synonym Hypericum aureum in certain classifications. Furthermore, its complex botanical identity includes connections to several subspecies of Hypericum chinense, specifically subsp. latifolium, subsp. obtusifolium, and subsp. salicifolium. Understanding these diverse naming conventions is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Hypericum monogynum belongs to the vast kingdom Plantae, representing a diverse branch of the living world. Within this realm, the species is classified under the class Equisetopsida. It further falls into the order Malpighiales, a group known for its botanical complexity. The plant is a distinct member of the genus Hypericum, which characterizes its specific morphological traits. Finally, it is nested within the family Hypericaceae, completing its formal taxonomic lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Hypericaceae |
| Genus | Hypericum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Hypericum monogynum exhibits a broad and diverse geographical distribution spanning multiple continents and climates. In the African region, this species can be found throughout the Western Indian Ocean, including the islands of Mauritius and Réunion. Its presence extends significantly into the temperate regions of Asia, specifically within the vast landscapes of China. Within China, the plant is well-established across the North-Central, South-Central, and Southeast provinces. This wide-ranging habitat demonstrates the remarkable adaptability of the species to varying ecological environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Hypericum monogynum is a self-supporting plant that typically exhibits a shrub-like growth form. This species maintains a compact stature, with its height generally ranging from a minimum of 0.5 m to a maximum of 1.3 m. Depending on specific environmental conditions, it often settles into a more consistent height of at least 0.9 m. These physical characteristics make it a versatile addition to various landscapes. Its sturdy structure ensures it remains upright without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Hypericum monogynum exhibits significant therapeutic potential through its diverse bioactive compounds. Research indicates that flavonoid derivatives isolated from its flowers possess potent antidiabetic activities by ameliorating insulin resistance. These specific compounds work by modulating key metabolic pathways and enhancing glucose uptake in resistant cells. Additionally, the plant's roots contain polyprenylated xanthones that demonstrate remarkable neuroprotective effects against cellular lesions. Together, these findings suggest that the species could play a vital role in developing treatments for metabolic disorders and depression.
Compounds
Hypericum monogynum is a plant rich in diverse bioactive compounds that contribute to its significant medicinal potential. Research has identified several key constituents within the species, including the flavone and the glycoside hyperoside. Detailed studies into the plant's chemical makeup have also isolated specific compounds such as hyperielliptone HA from its flowers. Furthermore, the presence of furohyperforin has been noted, with its structural configuration potentially playing a critical role in neuroprotective activities. Together, these various phytochemicals highlight the complex chemical profile that defines this important botanical species.
Conditions
Hypericum monogynum contains bioactive compounds like chipericumin D that offer therapeutic potential for treating calcific aortic valve disease (CAVD) by inhibiting osteogenic differentiation. The plant's extracts also provide multidrug resistance modulators, such as hypermoins, which are effective in treating the HepG2/ADR and MCF-7/ADR cancer cell lines. Furthermore, certain polycyclic polyprenylated acylphloroglucinol derivatives from the plant exhibit neuroprotective activity against KCl-induced SH-SY5Y cell injury. Flavonoid derivatives isolated from its flowers further assist in treating associated metabolic disorders by ameliorating insulin resistance in HepG2 cells. Together, these diverse chemical constituents demonstrate the plant's broad pharmacological utility across cardiovascular, oncological, neurological, and metabolic health.
Preparations
Hypericum monogynum is prepared as an extract to isolate bioactive compounds like chipericumin D, which shows potential in inhibiting cell calcification. This plant is also prepared as flowers to facilitate the bioactivity-guided isolation of specific flavonoid derivatives. These floral derivatives, such as HM 104 and HM 111, are utilized to study their effects on modulating insulin resistance. Both the extracted compounds and those derived from the flowers demonstrate significant roles in regulating metabolic signaling pathways. Consequently, the various preparations of Hypericum monogynum serve as vital sources for identifying therapeutic agents against cardiovascular and metabolic disorders.
Parts used
Hypericum monogynum is a versatile plant species that yields a diverse array of bioactive compounds from various anatomical structures. Research has successfully isolated unique polyprenylated acylphloroglucinols and flavonoids, such as hyperoside, from the flowers and flower buds. The leaves and twigs of the plant also serve as significant sources for discovering new chromanopyrones, flavones, and neuroprotective PPAP derivatives. Furthermore, the roots of the species contain specialized polyprenylated tetraoxygenated xanthones that demonstrate potential for antidepressant therapies. Through the study of these different parts, scientists continue to uncover the complex chemical profile and therapeutic possibilities of this plant.